We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ELEV market cap is 22.48M. The company's latest EPS is USD -0.7511 and P/E is -0.51.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.87M | -10.96M | -13.23M | -10.64M | -14.22M |
| Net Income | -10.71M | -10.46M | -12.88M | -10.44M | -14.21M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -32.05M | -94.55M | -45.45M | -44.7M |
| Net Income | -32.04M | -95.08M | -45.7M | -44.49M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 108.96M | 114.6M | 106.3M | 95.63M | 82.22M |
| Total Liabilities | 33.14M | 33.68M | 36.95M | 35.6M | 35.49M |
| Total Equity | 75.82M | 80.92M | 69.36M | 60.03M | 46.73M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 149.49M | 94.16M | 89.09M | 95.63M |
| Total Liabilities | 8.8M | 45.13M | 34.28M | 35.6M |
| Total Equity | 140.7M | 49.03M | 54.81M | 60.03M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -9.58M | -17.78M | -26.16M | -36.36M | -12.71M |
| Investing | 20.7M | -16.96M | -19.83M | -8.37M | 23.76M |
| Financing | 30.25M | 44.93M | 44.94M | 44.94M | -17k |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -30.17M | -85.48M | -56.18M | -36.36M |
| Investing | N/A | -44.4M | 11.54M | -8.37M |
| Financing | 97.05M | 29.51M | 47.98M | 44.94M |
| Market Cap | 22.48M |
| Price to Earnings Ratio | -0.51 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.45 |
| Price to Book Ratio | 0.37 |
| Dividend Yield | - |
| Shares Outstanding | 59.22M |
| Average Volume (1 week) | 391.65k |
| Average Volume (1 Month) | 988.8k |
| 52 Week Change | -86.10% |
| 52 Week High | 3.28 |
| 52 Week Low | 0.221 |
| Spread (Intraday) | 0.01 (2.37%) |
| Company Name | Elevation Oncology Inc |
| Address |
2140 s dupont hwy camden, delaware 19934 |
| Website | https://www.elevationoncology.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
